Khiron Life Sciences Sees CFO Resign, Appoints Third-Party Interim

Khiron Life Sciences Corp. (TSXV: KHRN) announced on Friday after the closing bell that its chief financial officer Joel Friedman has resigned. The company’s board has tapped the services of fractional CFO and accounting services provider, RTB LLP, for the interim.

The announcement comes weeks after the firm reported its renewal of the share buyback program. Although deemed as a renewal, the firm continued to expand the share count multiple times over the last year.

Friedman stepped in as CFO on October 16, 2020, just under a year ago. He replaced Wendy Kaufman who served as CFO since July 2019 until her resignation “to return to the mining industry where she has spent the greater part of her executive career”.

Altamira Gold Corp. — sponsored Sponsored · Altamira Gold Corp.

In a press release about his CFO appointment back in October 2020, Friedman was described as “the natural successor” to Kaufman after working closely with her since he started in the firm in December 2019 as finance and treasury director. He was touted to bring his 10 years of international financial experience, including his former role as the vice president for finance at cannabis firm CannTrust.

The cannabis firm is tapping RTB LLP, represented by Swapan Kakumanu, for the role of interim CFO effective immediately. According to the financial agency’s website, Kakumanu “has more than 25 years of senior finance and operations experience”. He has also served in senior management roles in different fields, including high-growth technology, manufacturing, blockchain, medical device, and oil field services industries.

The cannabis firm said Friedman will remain with the company until October 31, 2021, to provide transitional support.

Khiron Life Sciences last traded at $0.275 on the TSX Venture.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Mining Stock Mailbag: Hycroft, Vizsla, K92, Goliath & More | Oct. 5-9, 2026

Why Investors Are Returning To Mining Stocks | Rob McLeod – Cambria Gold Mines

How This Gold Stock Delivered a 32X Return | Martino De Ciccio – Montage Gold

Recommended

First Majestic Produces 3.4 Million Ounces of Silver in Q3 2026, Jerritt Canyon Restart Remains on Track

Altamira Gold Drills 134 Metres of 0.5 g/t Gold at Maria Bonita, Hole Ends in Mineralization

Related News

Khiron Life Sciences: An Essential Service of Colombia

Khiron Life Sciences (TSXV: KHRN) is uniquely positioned as a global integrated medical cannabis company....

Friday, April 24, 2020, 12:29:21 PM

Khiron Imports First Product To UK, Receives First European Prescriptions

Khiron Life Sciences (TSXV: KHRN) has officially entered the United Kingdom’s medical cannabis market, announcing...

Wednesday, May 6, 2020, 08:34:00 AM

Khiron Life Sciences X Nimbus Health

Khiron Life Sciences (TSXV: KHRN, OTCQX: KHRNF, Frankfurt: A2JMZC) is the latest cannabis company to...

Sunday, August 16, 2020, 09:00:00 AM

Khiron Life Sciences Conducts Bought Deal Financing For Gross Proceeds Of $10.0 Million

Khiron Life Sciences (TSXV: KHRN) announced that it is conducting at $10.0 bought deal private...

Monday, November 9, 2020, 08:43:24 AM

Harvest Moon: Khiron Life Sciences Posts Encouraging Earnings

Overall, we view the recent announcements and earnings surrounding Khiron Life Sciences (TSXV: KHRN) as...

Tuesday, May 5, 2020, 08:50:19 AM